AS IV treatment reduced the serum levels of lipopolysaccharide, which is an important serological index for monitoring abnormal glucose metabolism (Tola A Faraj and Erridge, 2017), TNF-α, and IL6 in the GDM model. The gene discussed is IL6; the disease is gestational diabetes.